How big is CASI Pharmaceuticals, Inc.?

Jun 22 2025 06:30 PM IST
share
Share Via
As of Jun 18, CASI Pharmaceuticals, Inc. has a market capitalization of 23.38 million and reported net sales of 31.37 million, with a net profit loss of 40.47 million. Shareholder's funds were 1.85 million, and total assets were 53.67 million.
As of Jun 18, CASI Pharmaceuticals, Inc. has a market capitalization of 23.38 million, categorizing it as a Micro Cap company.

As of Jun 18, the company reported net sales of 31.37 million for the latest four quarters. However, it also experienced a net profit loss of 40.47 million during the same period.

As of Dec 24, the reporting period shows that shareholder's funds amounted to 1.85 million, while total assets were recorded at 53.67 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News